OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities
NCT06890169 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2025-03-21
Summary
The goal of this clinical trial is to learn if the use of a care model including teleconsults and the EMPOWER app can induce clinically significant weight loss and metabolic improvements in obese adults with diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD).
Researchers will compare this model with the conventional standard of care of physical visit-based weight management program to see if this model is non-inferior to the standard of care for inducing weight loss, and if there is greater patient convenience with telehealth and more frequent self-monitoring, compliance with diet advice and exercise participation compared to standard of care.
Participants in the standard arm will attend 4 physical doctor and 4 physical dietician consultations over 26 weeks, where they will be provided with an individualized diet and exercise prescription to induce at least 5% weight loss.
Participants in the intervention arm will have the same number of consults over 26 weeks, of which at least 50% will be teleconsults, and will also be provided with an individualized diet and exercise prescription to induce at least 5% weight loss. In addition, they will be taught to use the EMPOWER app to upload weight, blood pressure and glucose, food and exercise records which will be reviewed at the consults. The app also delivers nudges to improve adherence to lifestyle modification.
Conditions
- Obesity and Type 2 Diabetes
- NAFLD - Non-Alcoholic Fatty Liver Disease
- Hypertension
- Dyslipidaemia
- Telemedicine
Interventions
- BEHAVIORAL
-
OneSTOP program
The OneSTOP program will incorporate at least 50% (4 out of 8 sessions) of the doctor and dietician consults over the 26-week study as teleconsults, which may be scheduled as joint or asynchronous consults. The exercise prescription and calorie restriction will be tailored to each subject's individual needs as in the F2F structured weight management program in the control group. In addition, participants will be taught to use the EMPOWER app will be used to enable them to upload their weight, blood pressure and glucose, food and exercise duration records. The app also has the capability to co-ordinate visits and investigations, deliver intelligent health nudges and reminders on adherence to treatment which can be individualized to their progress, and provide information on their conditions curated by their doctors and dieticians.
- BEHAVIORAL
-
Standard of care weight management program
The standard face-to-face weight management program consists of 4 doctor and 4 dietician consults over 26 weeks, at 2-4 weekly intervals in the first 3 months, and 6-8 weeks in the next 3 months. At the baseline visit, participants are provided with an aerobic and resistance exercise prescription individualized to each subject's fitness and comorbidities to target at least 180 minutes/week of moderate-intensity physical activity (with exercise on at least 3 days/week), and dietary advice based on a calorie-deficit diet (400-600 kilocalories less than the calculated daily caloric requirement, based on the Mifflin-St Jeor equation) which emphasizes reduction in sugar-sweetened beverages, refined carbohydrates and saturated fats. Subjects will be provided with a list of fitness resources such as gyms and fitness corners with advice on use of the equipment, and specific guidance on increasing intensity and duration of exercise and monitoring for injury.
Sponsors & Collaborators
-
National University of Singapore
collaborator OTHER -
Changi General Hospital
lead OTHER
Principal Investigators
-
Joan Khoo, MBBS, FRCP · Changi General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-01
- Primary Completion
- 2027-02-28
- Completion
- 2027-08-31
Countries
- Singapore
Study Locations
More Related Trials
-
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167 ·Status: ENROLLING_BY_INVITATION
-
Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (TANGO Study)
NCT05259475 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
NCT04807959 ·Status: COMPLETED
-
Metabolic Effects of Birth Weight on Overweight and Obese Chinese Adults and Their Responses to Weight Loss
NCT01080378 ·Status: UNKNOWN ·Phase: NA
-
Liver Health and Metabolic Function in People With Obesity
NCT03701828 ·Status: COMPLETED ·Phase: NA
-
Impact of Weight Loss on Mitochondrial Function
NCT07023133 ·Status: NOT_YET_RECRUITING
-
Metabolically Normal and Metabolically Abnormal Obesity
NCT01184170 ·Status: COMPLETED ·Phase: NA
-
To Investigate the Influence of Ethnicity in Metabolic Disease in Healthy, Overweight and Obese Subjects
NCT00988819 ·Status: UNKNOWN
-
Obesity Queue Database
NCT06391320 ·Status: RECRUITING
-
The MULTISITE Study
NCT05699863 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cryolipolysis on Localized Adiposity
NCT03160976 ·Status: UNKNOWN ·Phase: NA
-
Impact of Weight Loss Surgery in Adolescents With NAFLD
NCT02952170 ·Status: COMPLETED ·Phase: NA
-
Low-Calorie Diet in People With Prediabetes/Metabolic Syndrome
NCT04786418 ·Status: COMPLETED ·Phase: NA
-
WeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXercise
NCT06576050 ·Status: ACTIVE_NOT_RECRUITING
-
Weight Management in Nonalcoholic Steatohepatitis
NCT00266019 ·Status: COMPLETED ·Phase: PHASE2
-
STAGES Trial: Study of Adiposity, Growth and Endocrine Stages
NCT01460784 ·Status: COMPLETED
-
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195 ·Status: NOT_YET_RECRUITING
-
Metabolic Phenotyping for Personalized Obesity Therapy
NCT06874270 ·Status: RECRUITING
-
Vigorous- Versus Moderate-intensity Exercise to Reduce Liver Fat in Adults With Obesity and NAFLD
NCT06124456 ·Status: RECRUITING ·Phase: NA
-
Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema
NCT03271034 ·Status: COMPLETED ·Phase: NA
-
Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents
NCT05685017 ·Status: COMPLETED
-
Feasibility of the Paso Program for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease
NCT06854185 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fat Tissue Microperfusion to Measure Leptin Secretion and Its Relations With Fat Breakdown in Humans
NCT00001722 ·Status: COMPLETED
-
Effect of Abdominal Obesity on Lipoprotein Metabolism
NCT00438061 ·Status: COMPLETED ·Phase: PHASE3
-
Resistance Training in Patients With Morbid Obesity
NCT03921853 ·Status: COMPLETED ·Phase: NA